肝炎病毒检测的情况和将检测阳性个体与专家联系起来的措施:对日本千叶专门研究肝病的机构的调查

Kanzo Pub Date : 2023-10-01 DOI:10.2957/kanzo.64.517
Masato Nakamura, Soichiro Kiyono, Kentaro Fujimoto, Tadayoshi Kogure, Sae Yumita, Keita Ogawa, Terunao Iwanaga, Miyuki Nakagawa, Kisako Fujiwara, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Kazufumi Kobayashi, Naoya Kanogawa, Takayuki Kondo, Sadahisa Ogasawara, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Jun Kato, Naoya Kato
{"title":"肝炎病毒检测的情况和将检测阳性个体与专家联系起来的措施:对日本千叶专门研究肝病的机构的调查","authors":"Masato Nakamura, Soichiro Kiyono, Kentaro Fujimoto, Tadayoshi Kogure, Sae Yumita, Keita Ogawa, Terunao Iwanaga, Miyuki Nakagawa, Kisako Fujiwara, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Kazufumi Kobayashi, Naoya Kanogawa, Takayuki Kondo, Sadahisa Ogasawara, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Jun Kato, Naoya Kato","doi":"10.2957/kanzo.64.517","DOIUrl":null,"url":null,"abstract":"A questionnaire survey of medical institutions Chiba Prefecture, Japan, specializing in liver diseases was conducted. This study aimed to provide an overview of the current hepatitis virus tests situations and measures taken to link test-positive individuals to specialists. The positivity rate in these institutions was high, with 2.2% for hepatitis C antibody (HCVAb) and 0.9% for hepatitis B surface antigen (HBsAg). Although many institutions (70%) had been employing linking measures, the consultation rate with hepatologists was low, with 7.6% and 14.3% for HCVAb- and for HBsAg-positive cases, respectively. Only half of the institutions disclosed that their measures were working well. These data suggested the importance of improving the system for determining test-positive individuals and promoting hepatologist consultation.","PeriodicalId":17925,"journal":{"name":"Kanzo","volume":"205 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Situation of hepatitis virus tests and measures to link test-positive individuals to specialists: a survey of institutions in Chiba, Japan, specializing in liver diseases\",\"authors\":\"Masato Nakamura, Soichiro Kiyono, Kentaro Fujimoto, Tadayoshi Kogure, Sae Yumita, Keita Ogawa, Terunao Iwanaga, Miyuki Nakagawa, Kisako Fujiwara, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Kazufumi Kobayashi, Naoya Kanogawa, Takayuki Kondo, Sadahisa Ogasawara, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Jun Kato, Naoya Kato\",\"doi\":\"10.2957/kanzo.64.517\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A questionnaire survey of medical institutions Chiba Prefecture, Japan, specializing in liver diseases was conducted. This study aimed to provide an overview of the current hepatitis virus tests situations and measures taken to link test-positive individuals to specialists. The positivity rate in these institutions was high, with 2.2% for hepatitis C antibody (HCVAb) and 0.9% for hepatitis B surface antigen (HBsAg). Although many institutions (70%) had been employing linking measures, the consultation rate with hepatologists was low, with 7.6% and 14.3% for HCVAb- and for HBsAg-positive cases, respectively. Only half of the institutions disclosed that their measures were working well. These data suggested the importance of improving the system for determining test-positive individuals and promoting hepatologist consultation.\",\"PeriodicalId\":17925,\"journal\":{\"name\":\"Kanzo\",\"volume\":\"205 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kanzo\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2957/kanzo.64.517\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kanzo","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2957/kanzo.64.517","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

对日本千叶县肝病专业医疗机构进行问卷调查。本研究旨在概述当前肝炎病毒检测情况,并采取措施将检测阳性个体与专家联系起来。这些机构的阳性率很高,丙型肝炎抗体(HCVAb)阳性率为2.2%,乙型肝炎表面抗原(HBsAg)阳性率为0.9%。尽管许多机构(70%)采取了联系措施,但向肝病学家咨询的比例很低,HCVAb阳性病例和hbsag阳性病例分别为7.6%和14.3%。只有一半的机构透露,它们的措施效果良好。这些数据表明,改善检测阳性个体的确定系统和促进肝病专家咨询的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Situation of hepatitis virus tests and measures to link test-positive individuals to specialists: a survey of institutions in Chiba, Japan, specializing in liver diseases
A questionnaire survey of medical institutions Chiba Prefecture, Japan, specializing in liver diseases was conducted. This study aimed to provide an overview of the current hepatitis virus tests situations and measures taken to link test-positive individuals to specialists. The positivity rate in these institutions was high, with 2.2% for hepatitis C antibody (HCVAb) and 0.9% for hepatitis B surface antigen (HBsAg). Although many institutions (70%) had been employing linking measures, the consultation rate with hepatologists was low, with 7.6% and 14.3% for HCVAb- and for HBsAg-positive cases, respectively. Only half of the institutions disclosed that their measures were working well. These data suggested the importance of improving the system for determining test-positive individuals and promoting hepatologist consultation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
要介護C型慢性肝炎患者の受診促進のための取り組み~C型肝炎版ソーシャルインクルージョン~ De novo hepatitis B in a patient with negative hepatitis B core antibody and high normal range hepatitis B surface antibody treated with R-CHOP therapy for Diffuse large B-cell lymphoma 進行肝細胞癌に対するアテゾリズマブ+ベバシズマブ併用療法中に生じた皮膚筋炎の一例 Effectiveness of an Alert System for Hepatitis Viruses including Hepatitis B Virus Reactivation Operated by Hepatitis Medical Care Coordinators 肝線維症治療薬の開発:分子細胞基盤と克服すべき課題
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1